PharmaTimes looks PM Andy Burnham in the eye and asks, what are you going to do for us? We also stare down the ubiquitous AI ...
Transgene and Bispebjerg and Frederiksberg Hospital, University of Copenhagen, have announced that the first patient has been ...
Nxera Pharma has entered into an exclusive global licensing agreement with AbbVie for NXE0033744, an investigational oral EP4 ...
A new £30 million venture philanthropy fund is being launched to accelerate the development of treatments, diagnostics and technologies aimed at finding a cure for myeloma, an incurable blood cancer ...
Teva Pharmaceutical Industries and Samsung Bioepis have announced a new licensing and commercialisation agreement covering ...
Santersus is advancing NUC‑CAP, a multicentre, randomised pivotal study of NucleoCapture, its investigational extracorporeal ...
Octane Biotech and Currus Biologics have automated the manufacturing process for CUR‑001 on Octane’s Cocoon platform, ...
Panthera has opened its expanded Glasgow Clinical Research Centre at the Health Innovation Hub, increasing capacity for ...
The ExoCordOA consortium has launched a five‑year, €13 million Horizon Europe project to advance extracellular ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results